Literature DB >> 2804924

Pregnancy outcome after treatment for acute lymphoblastic leukemia during childhood or adolescence.

D M Green1, B Hall, M A Zevon.   

Abstract

To evaluate gonadal function and pregnancy outcome after treatment for acute lymphoblastic leukemia during childhood or adolescence, 44 former patients who were less than 20 years of age at diagnosis, 5 or more years from diagnosis, and 18 or more years of age were contacted. Thirty-nine (88%) provided information regarding pregnancy outcome. Gonadal function as estimated by the ability to conceive or sire a pregnancy, was not impaired despite treatment with substantial cumulative doses of methotrexate, 6-mercaptopurine, vincristine, and 1-asparaginase. Twelve patients reported a total of 27 pregnancies. There were four spontaneous abortions, one stillborn, and 22 liveborn infants. The birthweights were 1928 to 4536 g (median, 3430 g). Two infants had congenital anomalies. The childrens' ages ranged from 1 month to 10 years, 2 months (median, 6 years, 1 month). None has been diagnosed with any type of childhood cancer. The results of this study suggest that pregnancy outcome is not affected adversely by treatment received during childhood or adolescence for acute lymphoblastic leukemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2804924     DOI: 10.1002/1097-0142(19891201)64:11<2335::aid-cncr2820641124>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  The Gynecologist Has a Unique Role in Providing Oncofertility Care to Young Cancer Patients.

Authors:  Francesca E Duncan; Jennifer K Jozefik; Alison M Kim; Jennifer Hirshfeld-Cytron; Teresa K Woodruff
Journal:  US Obstet Gynecol       Date:  2011-01-01

2.  Genetic disease in offspring of long-term survivors of childhood and adolescent cancer.

Authors:  J Byrne; S A Rasmussen; S C Steinhorn; R R Connelly; M H Myers; C F Lynch; J Flannery; D F Austin; F F Holmes; G E Holmes; L C Strong; J J Mulvihill
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

Review 3.  Late effects of antineoplastic therapy in childhood on growth and endocrine function.

Authors:  W H Wallace; C J Kelnar
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

4.  Preterm delivery among female survivors of childhood, adolescent and young adulthood cancer.

Authors:  Laura-Maria Madanat-Harjuoja; Nea Malila; Päivi M Lähteenmäki; John D Boice; Mika Gissler; Tadeusz Dyba
Journal:  Int J Cancer       Date:  2010-10-01       Impact factor: 7.396

Review 5.  Strategies for fertility preservation in young patients with cancer: a comprehensive approach.

Authors:  Devika Gunasheela; Sulochana Gunasheela
Journal:  Indian J Surg Oncol       Date:  2014-02-26

6.  The risk of preterm birth among women with a history of leukemia or lymphoma.

Authors:  Sonia T Anand; Elizabeth A Chrischilles; Rebecca J Baer; Mary E Charlton; Patrick J Breheny; William W Terry; Monica R McLemore; Deborah A Karasek; Laura L Jelliffe-Pawlowski; Kelli K Ryckman
Journal:  J Matern Fetal Neonatal Med       Date:  2021-04-08

7.  Cancer in the offspring of survivors of childhood leukaemia and non-Hodgkin lymphomas.

Authors:  M M Hawkins; G J Draper; D L Winter
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

8.  Adverse obstetric and perinatal outcomes following treatment of adolescent and young adult cancer: a population-based cohort study.

Authors:  Fatima A Haggar; Gavin Pereira; David Preen; C D'Arcy Holman; Kristjana Einarsdottir
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.